[Molecular-targeted therapy of multiple myeloma].
Iida
Shinsuke
S
D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D016503:Drug Delivery Systems; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use*; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
D001897:Boronic Acids; D007155:Immunologic Factors; D011480:Protease Inhibitors; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide